Erythromycin 250 Mg Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 250 mg, 500 mg
Reference Brands: Erythrocin (USA/EU), EryPed (USA)
Category:
Antibiotics
Erythromycin Tablet is a medicine that is used for the treatment of Bacterial Infection and other conditions also.
Erythromycin Tablet contains Erythromycin as an active ingredient mainly.Erythromycin Tablet works by inhibiting the bacterial growth and showing its action.
Erythromycin 250 mg Tablets is available in Tablets
and strengths such as 250 mg, 500 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Erythromycin 250 mg Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Erythromycin 250 mg Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Erythromycin Tablet is used for the treatment, control, prevention, & improvement of the following diseases and symptoms: Bacterial Infection
Erythromycin is a widely used macrolide antibiotic effective against a variety of bacterial infections. It works by inhibiting bacterial protein synthesis, thereby preventing the growth and multiplication of susceptible bacteria. Due to its broad antimicrobial activity, erythromycin has been traditionally prescribed for several respiratory tract infections, including community-acquired pneumonia and Legionnaires’ disease. It is also commonly used for the treatment of skin and soft tissue infections, chlamydial infections, and certain sexually transmitted diseases.
Erythromycin is approved by the U.S. Food and Drug Administration for multiple therapeutic uses, including the treatment of skin infections, intestinal amebiasis, syphilis, and pelvic inflammatory disease (PID). In addition, it is used in the prevention of neonatal conjunctivitis and as prophylaxis in patients with a history of rheumatic fever who are allergic to penicillin.
In dermatology, erythromycin is sometimes combined with topical agents such as Tretinoin or Benzoyl Peroxide to help manage acne by reducing bacterial growth and inflammation. Available in multiple dosage forms including tablets, injections, and oral suspensions, erythromycin remains an important antibiotic in both hospital and outpatient treatment settings when used under appropriate medical supervision.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing